small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (564)
  • Capabilities (84)
  • Experience (393)
  • Insights & News (2,836)
  • Other Results (86)

Professionals 564 results

Bradley C. Vaiana
Bradley C. Vaiana
Partner
  • New York
Email
+1 212-294-2610
vCard

Partner

  • New York
David A. Sakowitz
David A. Sakowitz
Partner
  • New York, 
  • London
Email
+1 212-294-2639
vCard

Partner

  • New York
  • London
Matt Stockstill
Matt Stockstill
Partner
  • Dallas
Email
+1 214-453-6449
vCard

Partner

  • Dallas
View All Professionals

Capabilities 84 results

Practice Area

Private Equity

Winston & Strawn’s private equity attorneys provide strategic advice and legal counsel to middle-market private equity funds, hedge funds, family offices, real estate funds, alternative asset managers, portfolio companies, and institutional investors. We have one of the broadest and most active national middle-market private equity practices in the U.S. ...Read more

Practice Area

Capital Markets

Our capital markets and securities attorneys represent U.S. and international issuers, institutional investors, underwriters, and placement agents in a wide variety of public and private offerings of debt and equity securities....Read more

Practice Area

Secondaries & Liquidity Solutions

Winston & Strawn’s Secondaries and Liquidity Solutions group delivers market-leading counsel to clients navigating the evolving landscape of private fund liquidity, secondaries transactions, and bespoke capital solutions. Our multidisciplinary team advises private fund sponsors, institutional investors, and asset managers on the full spectrum of private investment fund secondary market activity, from traditional LP portfolio sales to complex GP-led transactions and innovative liquidity structures. Our attorneys are consistently recognized by leading private equity corporate publications, including Chambers, Legal 500, and others....Read more

Experience 393 results

Experience

|

July 17, 2025

D. Boral Capital Closes US$15M Robot Consulting IPO

Experience

|

July 15, 2025

Atsion Commits Up to $200 Million in Strategic OFA Investment

Experience

|

July 15, 2025

Winston Represented Cuadrilla Capital in the Acquisition of TigerGraph

View All Experience

Insights & News 2,836 results

Sponsorship

|

September 18, 2025

Winston & Strawn Sponsors 21st Annual Boardroom Summit

Winston & Strawn is sponsoring the upcoming 21stAnnual Boardroom Summit & Board Committee Peer Exchange. This unique event will bring industry leading public company directors to discuss current trends, including shareholder activism, CEO succession strategies, and uses of AI in the boardroom....Read more

Speaking Engagement

|

August 21, 2025

Partner Mike Blankenship Speaks with Crypto Law Summit

Mike Blankenship, Co-Chair, Capital Markets Practice, will be the featured speaker during Crypto Law Summit’s Taking Crypto Companies Public: IPO Strategies in the Digital Asset Era webinar....Read more

Recognitions

|

August 11, 2025

|

Less Than 1 Min Read

Winston & Strawn Recognized in 2025 IFLR1000 Rankings

Winston & Strawn is proud of its continued recognition in the 2025 edition of the IFLR1000, a leading guide to the world’s top financial and corporate transactional law firms and lawyers. In the United States, Winston is recognized in:...Read more
View All Insights & News

Other Results 86 results

Law Glossary

What Is Consumer Marketing Law?

Consumer marketing law is a broad legal segment dealing with federal and state statutes, along with government regulations, established to ensure that marketing and advertising are truthful. Federal law states that no form of advertising, including online advertising, can be deceptive. Marketing claims must also be evidence-based....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more

Site Content

What Is an IPO?

An IPO is an initial public offering, in which shares of a private company are made available publicly for the first time, allowing a company to raise equity capital from public investors. Companies must meet specific legal, governance, and accounting requirements imposed by the securities exchanges and the Securities and Exchange Commission (SEC) to conduct an IPO. Companies hire investment banks to market the offering, evaluate investor demand, and set the IPO price....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising